Efficacy and safety of once-weekly semaglutide in elderly subjects with T2D: post hoc analysis of SUSTAIN 1–5 trials

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility